SYMBYX Biome

Gold Sponsor

SYMBYX Biome specializes in developing medical devices aimed at alleviating symptoms of Parkinson's disease and chronic pain. We are dedicated to delivering high-quality products, supported by rigorous research and robust clinical support, establishing ourselves as a globally trusted brand within the Parkinson's community. Our product portfolio currently includes six SYMBYX devices, all of which meet the ISO13485/MDSAP certification standards. We have conducted multiple randomized controlled trials (RCTs), including the notable SYMBYX Neuro helmet trial, which was published in The Lancet in 2023.

Currently, we are conducting four larger-scale Parkinson’s RCTs in Canada, Australia, the UK, and China. Additionally, SYMBYX is expanding its research to explore potential treatments for other conditions, such as inflammatory bowel disease (IBD), dementia and cognitive decline, renal failure, and ADHD.

Watch our promo video

CONNECT WITH OUR TEAM AT PBM2024